Lima J J, Shields B J, Howell L H, MacKichan J J
Ther Drug Monit. 1984;6(2):203-10. doi: 10.1097/00007691-198406000-00013.
The accuracy of determining disopyramide concentrations in 80 serum samples by high-performance liquid chromatography (HPLC) and fluorescence immunoassay (FIA) on 2 consecutive days was similar. The precision of both methods was excellent. The interday precision of FIA was superior to HPLC at nominal concentrations of 1.5 and 3.0 mg/L, but was similar at 7.0 mg/L. Following equilibrium dialysis of 40 serum samples, the unbound concentration of disopyramide determined by a modified FIA method under-estimated by 16% the unbound concentration determined by a reference method. The discrepancy may be avoided by preparing standards in the appropriate buffer. Fluorescence of disopyramide optical isomers at similar concentrations were identical. It is concluded that FIA for determining plasma concentrations of disopyramide is accurate and precise, and may be modified to accurately determine unbound concentrations following separation of plasma water and protein.
连续两天通过高效液相色谱法(HPLC)和荧光免疫分析法(FIA)测定80份血清样本中丙吡胺浓度的准确性相似。两种方法的精密度都很好。在标称浓度为1.5和3.0 mg/L时,FIA的日间精密度优于HPLC,但在7.0 mg/L时两者相似。对40份血清样本进行平衡透析后,改良FIA法测定的丙吡胺未结合浓度比参考方法测定的未结合浓度低16%。通过在适当的缓冲液中制备标准品可以避免这种差异。丙吡胺光学异构体在相似浓度下的荧光相同。结论是,用于测定丙吡胺血浆浓度的FIA准确且精密,并且在分离血浆水和蛋白质后可进行改良以准确测定未结合浓度。